ATE346302T1 - Nicht-a, nicht-b hepatitis virus antigen, und diagnostische verfahren. - Google Patents

Nicht-a, nicht-b hepatitis virus antigen, und diagnostische verfahren.

Info

Publication number
ATE346302T1
ATE346302T1 AT02006640T AT02006640T ATE346302T1 AT E346302 T1 ATE346302 T1 AT E346302T1 AT 02006640 T AT02006640 T AT 02006640T AT 02006640 T AT02006640 T AT 02006640T AT E346302 T1 ATE346302 T1 AT E346302T1
Authority
AT
Austria
Prior art keywords
sequence
nanbv
hutch
hcv
strain
Prior art date
Application number
AT02006640T
Other languages
English (en)
Inventor
Suzanne Zebedee
Genevieve Inchauspe
Marc S Nasoff
Alfred M Prince
Original Assignee
Bioprocess Pty Ltd
New York Blood Ct Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27416160&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE346302(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioprocess Pty Ltd, New York Blood Ct Inc filed Critical Bioprocess Pty Ltd
Application granted granted Critical
Publication of ATE346302T1 publication Critical patent/ATE346302T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT02006640T 1990-08-25 1991-08-23 Nicht-a, nicht-b hepatitis virus antigen, und diagnostische verfahren. ATE346302T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57364390A 1990-08-25 1990-08-25
US61636990A 1990-11-21 1990-11-21
US74856491A 1991-08-21 1991-08-21

Publications (1)

Publication Number Publication Date
ATE346302T1 true ATE346302T1 (de) 2006-12-15

Family

ID=27416160

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02006640T ATE346302T1 (de) 1990-08-25 1991-08-23 Nicht-a, nicht-b hepatitis virus antigen, und diagnostische verfahren.

Country Status (9)

Country Link
EP (2) EP0544838A4 (de)
KR (1) KR930702365A (de)
AT (1) ATE346302T1 (de)
AU (1) AU673135B2 (de)
CA (1) CA2090335A1 (de)
DE (1) DE69133552C5 (de)
DK (1) DK1227323T4 (de)
ES (1) ES2273934T5 (de)
WO (1) WO1992003458A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE185350T1 (de) * 1990-12-14 1999-10-15 Innogenetics Nv Synthetische antigene zum nachweis von antikörpern gegen hepatitis c virus
BR9206131A (pt) * 1991-06-10 1995-05-02 Lucky Ltd Hepatite C: diagnóstico e vacinas
KR0185426B1 (ko) 1991-06-24 1999-04-01 로버트 피. 블랙버언 씨형 간염 바이러스 폴리펩티드
DK0529493T3 (da) * 1991-08-27 1998-08-24 Hoffmann La Roche Fremgangsmåder og reagenser til hepatitis C-detektion
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
DE4240980A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV Peptidantigene und Verfahren zur Bestimmung von HCV
US6153378A (en) * 1992-10-16 2000-11-28 Bionova Corporation Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
AU6415394A (en) * 1993-03-25 1994-10-11 Envirocon International Incorporated Test kits and methods for rapidly testing for contamination by microorganisms
GB9507232D0 (en) * 1995-04-07 1995-05-31 Gatsby Charitable Foundation Plant pathogen resistance genes and uses thereof
CN1068334C (zh) * 1994-06-08 2001-07-11 北京医科大学 新型血吸虫疫苗肽(二)
CN1061991C (zh) * 1994-06-08 2001-02-14 北京医科大学 新型血吸虫疫苗肽(三)
CN1061990C (zh) * 1994-06-08 2001-02-14 北京医科大学 新型血吸虫疫苗肽(一)
WO2001051500A1 (en) 2000-01-14 2001-07-19 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
JP2005533855A (ja) 2002-07-24 2005-11-10 インターツェル・アクチェンゲゼルシャフト 病原性ウイルスからの別のリーディングフレームによりコードされる抗原
EP1537418A2 (de) 2002-09-13 2005-06-08 Intercell AG Verfahren zur isolierung von hepatitis c virus peptiden
AU2004224746B2 (en) 2003-03-24 2009-04-23 Valneva Austria Gmbh Improved vaccines
CA2530062A1 (en) 2003-07-11 2005-01-20 Intercell Ag Hcv vaccines

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744242A1 (de) * 1987-02-20 1989-07-06 Seelig Renate Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
WO1989004669A1 (en) * 1987-11-18 1989-06-01 Chiron Corporation Nanbv diagnostics and vaccines
AU624105B2 (en) * 1987-11-18 1992-06-04 Novartis Vaccines And Diagnostics, Inc. Nanbv diagnostics and vaccines
WO1990000597A1 (en) * 1988-07-06 1990-01-25 Genelabs Incorporated Post-transfusion, non-a, non-b hepatitis virus and antigens
IL91371A0 (en) * 1988-08-24 1990-04-29 Us Commerce Clones or vectors bearing dna sequences of non-a and non-b hepatitis and a method for detecting these materials in blood
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
JPH02167081A (ja) * 1988-12-21 1990-06-27 Tetsuo Nakamura 非Ａ非Ｂ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡおよびウイルス抗原蛋白質
HUT54896A (en) * 1989-03-17 1991-04-29 Chiron Corp Process for producing aquous diagnosticum and vaccine of nanbv

Also Published As

Publication number Publication date
AU8904191A (en) 1992-03-17
DE69133552D1 (de) 2007-01-04
EP1227323B1 (de) 2006-11-22
ES2273934T3 (es) 2007-05-16
EP0544838A1 (de) 1993-06-09
KR930702365A (ko) 1993-09-08
EP1227323A1 (de) 2002-07-31
DE69133552T2 (de) 2007-08-23
AU673135B2 (en) 1996-10-31
WO1992003458A1 (en) 1992-03-05
EP0544838A4 (en) 1997-09-10
EP1227323B2 (de) 2011-01-19
DK1227323T4 (da) 2011-04-26
DK1227323T3 (da) 2007-03-26
DE69133552C5 (de) 2008-01-10
ES2273934T5 (es) 2011-05-17
CA2090335A1 (en) 1992-02-26

Similar Documents

Publication Publication Date Title
DE69133552D1 (de) Nicht-A, nicht-B Hepatitis Virus Antigen, und diagnostische Verfahren.
Battegay et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2. 1 molecules
EP0725824B1 (de) Von menschlichen t-zellen immunodominante epiropen des virus der c-hepatitis
Nishizawa et al. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology
DE69518642D1 (de) Peptide zur induktion von immunantwort durch zytotoxischen t lymphocyten gegen das virus von hepatitis c
Martell et al. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation
HK38293A (en) Hepatitis c virus
ATE507312T1 (de) Nachweis und typisierung das hepatitis c virus (hcv) mittels 5'utr und ns5 nukleinsäuresequenzen
Kurokohchi et al. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region
DE68903165D1 (de) Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein.
EP0644894A1 (de) Peptid für die stimulierung von für hepatitis c virus spesifischen cytotoischen t lymphozyten.
Matsuura et al. The molecular biology of hepatitis C virus
Höhne et al. Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak
Okamoto et al. Full-length nucleotide sequence of a Japanese hepatitis C virus isolate (HC-J1) with high homology to USA isolates
US5789544A (en) Method for producing ectoprotein of hepatitis C virus
WO1995032290A3 (en) Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof
DK0551275T3 (da) Non-A non-B sekvenser
Major et al. Characterization of hepatitis C virus infectious clones in chimpanzees: long-term studies
Overby Hepatitis C: looking at a virus that hasn't been seen.
EP1010759A4 (de) Gen, polynukleotid, polypeptid und virion des non-b, non-c, non-g-hepatitis virus, eine methode zur abtrennung dieses virions und methoden für die virusdetektion.
KR950000880A (ko) 한국형 씨(c)형 간염 바이러스의 일종인 케이에이치씨브이-엘2(khcv-l2)의 전체 뉴클레오티드서열 및 이로부터 유추된 아미노산 서열
RU2004104357A (ru) Вакцинный состав, потенцированный комбинацией днк и антигена
KR950000881A (ko) 새로운 한국형 씨(C)형 간염 바이러스 씨디엔에이(cDNA) 절편의 뉴클레오티드 서열 및 이로부터 유추된 아미노산 서열
Mishiro et al. Diversity of the classification and nomenclature systems for hepatitis C virus genotypes: a proposed solution to the present confusion
MY105097A (en) Nanbv diagnostics and vaccines

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1227323

Country of ref document: EP

EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 1227323

Country of ref document: EP

EELA Cancelled due to lapse of time